source
- Jaguar LAA acquires Johnson & Johnson's Laminar atrial fibrillation device assetsJaguar LAA, a newly formed medtech company, announced it has purchased assets related to Johnson & Johnson's Laminar atrial fibrillation device program. The Laminar technology is a catheter‑based…
- Experts review five decades of regulatory evolution at RAPS Convergence 2026At the opening plenary of RAPS Convergence 2026 in Charlotte, NC, specialists in medical device and pharmaceutical regulatory affairs gathered to discuss the field’s trajectory. They reflected on…